FIELD: peptides, medicine, pharmacy.
SUBSTANCE: invention relates to synthetic peptides as antagonists in binding the growth transforming factor TGF-β1 with its receptors in body being this factor shows the sequence comprising from 2 to 15 amino acids that are identical or related with amino acids in the natural the growth transforming factor TGF-β1 and/or its receptors. Peptides can be used as active compounds for preparing compositions used in liver diseases, in particular, in liver fibrosis (cirrhosis).
EFFECT: valuable medicinal properties of peptides.
10 cl, 7 tbl, 28 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE CAPABLE OF BINDING WITH β AND INHIBITING BIOLOGICAL ACTIVITY OF β IN VITRO AND/OR IN VIVO, APPLICATION OF PEPTIDE, PHARMACEUTICAL COMPOSITION, DNA SEQUENCE, DNA STRUCTURE, EXPRESSION VECTOR, HOST-CELL AND METHOD OF OBTAINING PEPTIDE | 2004 |
|
RU2333917C2 |
| USE OF DNA SEQUENCE WHICH CODES PEPTIDE ABLE TO BIND WITH TRANSFORMING GROWTH FACTOR β1 (VERSIONS) | 2008 |
|
RU2455358C2 |
| APPLICATION OF INHIBITING TGF-beta1 PEPTIDES FOR PREPARATION OF AGENT MODULATING IMMUNE RESPONSE | 2005 |
|
RU2420307C2 |
| ANTAGONISTS OF ALPHAVBETA3 AND ALPHAVBETA6 INTEGRINS AND ANTIFIBROTIC AGENTS | 2004 |
|
RU2388472C2 |
| ADVANCED WOUND COVER FOR IMPROVING WOUND HEALING | 2000 |
|
RU2245722C2 |
| PEPTIDE ANALOGUE COMPOUNDS OF GROWTH HORMONE SECRETION STIMULANTS AND PREPARATIONS CONTAINING SAID COMPOUNDS | 2007 |
|
RU2416618C2 |
| ANTIBODY AGAINST IGF-I RECEPTOR | 2018 |
|
RU2785305C2 |
| STRUCTURED ANTI-TGF-BETA ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS | 2014 |
|
RU2681502C2 |
| THERAPEUTIC AGENT FOR MESOTHELIOMA | 2004 |
|
RU2392967C2 |
| HUMANISED MONOCLONAL ANTIBODIES TO HEPATOCYTE GROWTH FACTOR | 2007 |
|
RU2461570C2 |
